4.2 Article

Gut-brain cross-talk in appetite regulation

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MCO.0b013e32833b64a3

关键词

glucagon-like peptide-1; gut hormones; obesity; oxyntomodulin; pancreatic polypeptide; peptide YY

资金

  1. Pfizer
  2. Medical Research Council [G7811974] Funding Source: researchfish
  3. National Institute for Health Research [NF-SI-0507-10337] Funding Source: researchfish
  4. MRC [G7811974] Funding Source: UKRI

向作者/读者索取更多资源

Purpose of review To review the role of gut hormones involved in appetite regulation and their potential in the treatment of obesity. Recent findings The medical treatment of obesity has been fraught with challenges. With two centrally acting agents having been recently withdrawn from the market, new therapies are required. The gut hormones are especially promising therapeutic targets. This article looks at the interplay between gut and brain which mediates the regulation of appetite and energy expenditure. Some recent developments that point the way towards the future development of gut hormone analogues as treatments for obesity are reviewed. Summary Our understanding of the interaction between gut hormones and the neuronal circuits controlling appetite regulation has made great advances over recent years. This knowledge is essential if these peptides are to become potential obesity therapies, both from an efficacy and safety perspective.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据